SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: Hans U. Tschanz who wrote (45)3/22/2000 11:18:00 AM
From: Mike McFarland  Respond to of 598
 
Tularik Announces Pricing of Stock Offering
2,500,000 shares of common stock at a price of $35.125 per share. Of the shares being offered, 1,875,000 are being sold by Tularik and 625,000 are being sold by selling stockholders
biz.yahoo.com



To: Hans U. Tschanz who wrote (45)3/23/2000 7:19:00 AM
From: swisstrader  Read Replies (1) | Respond to of 598
 
Hans...I'm a buyer this a.m...big fallout complements of secondary and biotechs out of vogue...now all that is behind us...regards, swiss


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News